[1] Saeedi P, Petersohn I, Salpea P, et al.Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition[J]. Diabetes Res Clin Pr, 2019, 157: 107843. [2] Zheng Y, Ley SH, Hu FB.Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Rev Endocrinology, 2018, 14(2): 88-98. [3] Inaishi J, Saisho Y.Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review[J]. Nutrients, 2020, 12(12): 3846. [4] Hannon TS, Kahn SE, Utzschneider KM, et al.Review of methods for measuring β-cell function: Design considerations from the Restoring Insulin Secretion (RISE) Consortium[J]. Diabetes Obes Metab, 2018, 20(1): 14-24. [5] Bunney PE, Zink AN, Holm AA, et al.Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet[J]. Physiology &Behavior, 2017, 176: 139-148. [6] Guest PC.Biogenesis of the Insulin Secretory Granule in Health and Disease[J]. Adv Exp Med Biol, 2019, 1134: 17-32. [7] Galal MA, Alouch SS, Alsultan BS, et al.Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance[J]. Int J Mol Sci, 2023, 24(19): 15006. [8] Lin J, Song T, Li C, et al.GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer[J]. Biochim Biophys Acta Mol Cell Res, 2020, 1867(5): 118659. [9] Papazafiropoulou AK, Papanas N, Melidonis A, et al.Family History of Type 2 Diabetes: Does Having a Diabetic Parent Increase the Risk?[J]. Current Diabetes Reviews, 2017, 13(1): 19-25. [10] Kral BG, Becker DM, Yanek LR, et al.The relationship of family history and risk of type 2 diabetes differs by ancestry[J]. Diabetes Metabolism, 2019, 45(3): 261-267. [11] Al-Sulaiti H, Diboun I, Agha MV, et al.Metabolic signature of obesity-associated insulin resistance and type 2 diabetes[J]. J Transl Med, 2019, 17(1): 348. [12] Fang X, Miao R, Wei J, et al.Advances in multi-omics study of biomarkers of glycolipid metabolism disorder[J]. Comput Struct Biotechnol J,2022, 20: 5935-5951. [13] Marciniak SJ, Chambers JE, Ron D.Pharmacological targeting of endoplasmic reticulum stress in disease[J]. Nature Reviews Drug Discovery, 2022, 21(2): 115-140. [14] Yaribeygi H, Sathyapalan T, Atkin SL, et al.Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus[J]. Oxidative Medicine and Cellular Longevity, 2020, 2020: 8609213. [15] Ezraty B, Gennaris A, Barras F, et al.Oxidative stress, protein damage and repair in bacteria[J]. Nature Reviews Microbiology, 2017, 15(7): 385-396. [16] Singh A, Kukreti R, Saso L, et al.Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes[J]. Molecules, 2022, 27(3): 950. [17] Fang FS, Cheng XL, Gong YP, et al.Association between glycemic indices and beta cell function in patients with newly diagnosed type 2 diabetes[J]. Current Medical Research and Opinion, 2014, 30(8): 1437-1440. [18] Shen Y, Prinyawiwatkul W, Xu Z.Insulin: a review of analytical methods[J]. The Analyst, 2019, 144(14): 4139-4148. [19] Ahrén B, Pratley RE, Soubt M, et al.Clinical measures of islet function: usefulness to characterize defects in diabetes[J]. Current Diabetes Reviews, 2008, 4(2): 129-145. [20] Zhao Y, Li H.Association of serum leptin and insulin levels among type 2 diabetes mellitus patients: A case-control study[J]. Medicine (Baltimore), 2022, 101(41): e31006. [21] Beamish CA, Gaber AO, Fraga DW, et al.Pretransplant HOMA-β Is Predictive of Insulin Independence in 7 Patients With Chronic Pancreatitis Undergoing Islet Autotransplantation[J]. Transplant Direct, 2022, 8(10): e1367. [22] Mather KJ, Tjaden AH, Hoehn A, et al.Precision and accuracy of hyperglycemic clamps in a multicenter study[J]. American Journal of Physiology Endocrinology and Metabolism, 2021, 320(4): E797-E807. [23] Phillips PJ.Oral glucose tolerance testing[J]. Australian Family Physician, 2012, 41(6): 391-393. [24] Morettini M, Di Nardo F, Burattini L, et al.Assessment of glucose effectiveness from short IVGTT in individuals with different degrees of glucose tolerance[J]. Acta Diabetologica, 2018, 55(10): 1011-1018. [25] AL-Mrabeh A, Hollingsworth KG, Steven S, et al.Morphology of the pancreas in type 2 diabetes: effect of weight loss with or without normalisation of insulin secretory capacity[J]. Diabetologia, 2016, 59(8): 1753-1759. [26] Wu YJ, Fang ZH, Zheng SG.Effects of danzhi jiangtang Capsule combined exercise on pancreatic oxidative stress and islet beta-cell function in diabetic rats[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2012, 32(11): 1531-1534. [27] GRADE Study Research Group, Nathan DM, Lachin JM, et al. Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes[J]. The New England Journal of Medicine, 2022, 387(12): 1063-1074. [28] 曾静,方毅. 糖尿病药物治疗的现状及药物研究进展[J]. 临床药物治疗杂志,2017,15(10):1-5. [29] Razzaghy-Azar M, Nourbakhsh M, Talea A, et al.Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports[J]. Journal of Medical Case Reports, 2021, 15(1): 535. [30] Chen X, Lv X, Yang G, et al.Polyethylene glycol loxenatide injections added to metformin effectively improve glycemic control and exhibit favorable safety in type 2 diabetic patients[J]. Journal of Diabetes, 2017, 9(2): 158-167. [31] Lebovitz HE.Thiazolidinediones: the Forgotten Diabetes Medications[J]. Current Diabetes Reports, 2019, 19(12): 151. [32] Niswender KD.Basal insulin: physiology, pharmacology, and clinical implications[J]. Postgraduate Medicine, 2011, 123(4): 17-26. [33] 王勇,王存川,朱晒红,等. 中国肥胖及2型糖尿病外科治疗指南(2019版)[J]. 中国实用外科杂志,2019,39(4):301-306. [34] Zhang Y, Zhu C, Wen X, et al.Laparoscopic sleeve gastrectomy improves body composition and alleviates insulin resistance in obesity related acanthosis nigricans[J]. Lipids in Health and Disease, 2017, 16(1): 209. [35] Jørgensen NB, Jacobsen SH, Dirksen C, et al.Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance[J]. Am J Physiol Endocrinol Metab, 2012, 303(1): E122-131. [36] Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, et al.Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery[J]. Diabetes, 2003, 52(5): 1098-1103. |